STOCK TITAN

Baxter Intl Stock Price, News & Analysis

BAX NYSE

Company Description

Company Overview

Baxter International Inc is a diversified healthcare company renowned for its extensive portfolio of essential renal and hospital products. The company specializes in advanced dialysis solutions, infusion systems, and sterile IV products, underscoring its commitment to enhancing patient care. Baxter operates at the crossroads of cutting-edge medical technology and time-honored expertise, serving a broad spectrum of clinical environments from acute care hospitals to home-based patient settings.

Product and Service Portfolio

Baxter’s offerings encompass a wide range of critical medical supplies and devices designed to meet diverse healthcare needs. The company’s portfolio includes:

  • Renal and Dialysis Products: Comprehensive solutions for home, acute, and in-center dialysis, aiding in effective kidney care management.
  • Infusion Systems and Sterile IV Solutions: A robust selection of IV pumps, administration sets, and high-quality sterile solutions that facilitate safe and efficient patient therapy.
  • Nutritional and Parenteral Solutions: Specialized nutritional products and parenteral nutrition options that play a pivotal role in patient recovery and care.
  • Biosurgery Products and Anesthetics: Medical products such as surgical sealants and hemostatic agents that contribute to improved surgical outcomes and patient safety.
  • Pharmacy Automation and Software Services: Integrated systems designed to streamline pharmacy operations, ensuring optimal medication management and operational efficiency.

Global Footprint and Market Reach

Baxter’s operations extend across both emerging and developed markets, bolstering its position as a critical supplier of medical products globally. Its extensive distribution network underscores a commitment to expanding healthcare access worldwide by ensuring that essential medical supplies reach diverse healthcare environments. This global presence not only supports robust patient care infrastructures but also fosters resilience in addressing evolving clinical demands.

Operational Excellence and Innovation

At the heart of Baxter’s operations lies a strong legacy of medical breakthroughs paired with a constant drive for innovation. The company leverages deep industry insights and rigorous research and development initiatives to continuously refine and expand its product lines. Each category in its portfolio is developed with a deep understanding of regulatory requirements and clinical efficiency, thereby reinforcing its credibility among healthcare providers.

Competitive Landscape and Strategic Initiatives

Baxter operates in a dynamic competitive landscape characterized by rapid advancements in medical technology and patient care protocols. By integrating strategic acquisitions—such as the expansion into hospital equipment—the company has diversified its offerings to include essential assets like hospital beds, operating room devices, and patient monitoring systems. These strategic moves, combined with its longstanding expertise, allow Baxter to maintain a distinctive position amid market competition.

Commitment to Patient-Centered Healthcare

Diligently focused on enhancing patient outcomes, Baxter’s product innovations and global distribution strategies are designed to support healthcare professionals in delivering optimal patient care. Every facet of its operations—ranging from advanced renal care solutions to comprehensive hospital products—reflects a commitment to addressing the critical needs of clinical environments and fostering sustainable improvements in patient care delivery.

Stock Performance

$31.00
+1.94%
+0.59
Last updated: April 25, 2025 at 04:00
-24.94 %
Performance 1 year
$14.3B
Market Cap
512.9M
Shares outstanding

SEC Filings

No SEC filings available for Baxter Intl.

Financial Highlights

$2,699,000,000
Revenue (TTM)
$144,000,000
Net Income (TTM)
$0.27
Diluted EPS (TTM)
$253,000,000
Operating Cash Flow
5.34%
Net Profit Margin
5.74%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Baxter Intl (BAX)?

The current stock price of Baxter Intl (BAX) is $30.41 as of April 24, 2025.

What is the market cap of Baxter Intl (BAX)?

The market cap of Baxter Intl (BAX) is approximately 14.3B.

What is the revenue (TTM) of Baxter Intl (BAX) stock?

The trailing twelve months (TTM) revenue of Baxter Intl (BAX) is $2,699,000,000.

What is the net income of Baxter Intl (BAX)?

The trailing twelve months (TTM) net income of Baxter Intl (BAX) is $144,000,000.

What is the earnings per share (EPS) of Baxter Intl (BAX)?

The diluted earnings per share (EPS) of Baxter Intl (BAX) is $0.27 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Baxter Intl (BAX)?

The operating cash flow of Baxter Intl (BAX) is $253,000,000.

What is the profit margin of Baxter Intl (BAX)?

The net profit margin of Baxter Intl (BAX) is 5.34%.

What is the operating margin of Baxter Intl (BAX)?

The operating profit margin of Baxter Intl (BAX) is 5.74%.

What is the gross margin of Baxter Intl (BAX)?

The gross profit margin of Baxter Intl (BAX) is 38.27%.

What is the current ratio of Baxter Intl (BAX)?

The current ratio of Baxter Intl (BAX) is 1.43, indicating the company's ability to pay short-term obligations.

What is the gross profit of Baxter Intl (BAX)?

The gross profit of Baxter Intl (BAX) is $1,033,000,000 on a trailing twelve months (TTM) basis.

What is the operating income of Baxter Intl (BAX)?

The operating income of Baxter Intl (BAX) is $155,000,000.

What core business does Baxter International Inc focus on?

Baxter focuses on providing a diverse range of medical supplies including renal and dialysis products, sterile IV solutions, infusion systems, and hospital equipment that support critical patient care.

How does Baxter generate its revenue?

The company generates revenue through the sale of its comprehensive portfolio of healthcare products and devices, tailored to meet the clinical needs of hospitals, dialysis centers, and other care settings.

What are the primary product categories offered by Baxter?

Baxter offers products across several categories: renal and dialysis solutions, sterile IV products, infusion systems, nutritional and parenteral products, biosurgery items, and pharmacy automation services.

How does Baxter maintain its competitive edge in the healthcare industry?

Through continual innovation, strategic acquisitions, and a focus on expanding its product portfolio, Baxter effectively meets evolving clinical demands and maintains a robust global presence.

What is the scope of Baxter’s global operations?

Baxter operates in both emerging and developed markets, ensuring that its medical products and innovations reach a broad range of healthcare facilities, thereby enhancing global patient care delivery.

How are Baxter's products designed to support patient care?

Baxter's products are developed with a deep understanding of clinical needs and regulatory standards, incorporating features that ensure reliability, safety, and efficiency in various healthcare settings.

How does Baxter differentiate itself from its competitors?

The company's long-standing legacy of medical innovation, combined with its diversified product range and strategic market initiatives, enables it to address a wide spectrum of healthcare challenges effectively.